Company profile · Biotech & medical
永信國際投資控股股份有限公司 · 3705
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
YungShin Global Holding operates in general investment and functions as a multinational medical and health technology group.[1]
The company manufactures high-quality pharmaceuticals, health supplements, and veterinary drugs, and invests in the research and development of various therapeutic medicines.[2]
It also engages in elder care, health and leisure, healthcare, and medical cosmetology.[2]
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$749m | +4.4% | +13.7% |
2024-11 to 2026-10, monthly revenue.
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$92m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
| Full English name | YungShin Global Holding Corporation |
|---|---|
| Chinese name | 永信國際投資控股股份有限公司 |
| Stock code | 3705 (TWSE) |
| Industry | Biotech & medical |
| Founded | 03 Jan 2011 |
| Listed | 03 Jan 2011 |
| Paid-in capital | NT$2.7bn |
| Chairman | 李芳信 |
| President | 簡志維 |
| Headquarters | 12F., No. 181, Sec. 3, Minquan E. Rd., Songshan Dist., Taipei City 105, Taiwan |
| Website | https://www.yungshingroup.com |
| Official business description | 一般投資業 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Generated 2026-11-11 00:39.